Trial Profile

A Phase 3, Multicenter, Randomized, and Double-blind Study to Evaluate the Safety of Tigecycline versus a Ceftriaxone Regimen in the Treatment of Complicated Intra-abdominal Infections and Community-acquired Pneumonia in Pediatric Subjects Ages 8 to 17 Years Old

Status: Discontinued

Phase of Trial: Phase III

Latest Information Update: 02 Sep 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tigecycline (Primary) ; Aminoglycosides; Ceftriaxone; Clarithromycin; Metronidazole
Indications Bacterial infections; Community-acquired pneumonia; Intra-abdominal infections
Focus Registrational; Therapeutic Use
Sponsors Pfizer; Wyeth; Wyeth Pharmaceuticals

31 Aug 2024 This trial has been completed in Slovenia, according to European Clinical Trials Database
31 Jul 2022 This trial has been completed in Belgium, according to European Clinical Trials Database.
13 Jun 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com